Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia

Bo Yu(U.S. National Science Foundation), Natarajan Muthusamy(The Ohio State University)
Blood
November 20, 2012
Cited by 64


Related Papers